-
-
-
-
-
-
-
Milestone launches registry to study CARDAMYST nasal spray use
-
-
-
-
-
-
-
Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
-
-
-
-
-
-
-
Wells Fargo Starts Milestone Pharmaceuticals (MIST) at Overweight
-
-
-
-
-
-
-
TD Cowen Downgrades Milestone Pharmaceuticals (MIST) to Hold
-
-
-
-
-
-
-
Milestone Pharmaceuticals (MIST) Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC
-
-
-
-
-
-
-
Milestone Pharmaceuticals Inc. (MIST) Appoints Joseph Papa to its Board
-
-
-
460,443 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

